Loading...
Loading...
Browse all stories on DeepNewz
VisitOzempic Shows Promise in Reducing Advanced Alzheimer's Risk, Potential 70% Reduction in Dementia by 2025
Dec 26, 2024, 08:53 AM
Recent studies are exploring the potential of Ozempic, a weight-loss medication, to aid in the fight against advanced Alzheimer's disease. Scientists are investigating its anti-inflammatory properties, which may contribute to a significant reduction in the risk of developing dementia. Early findings indicate that patients receiving the medication could see up to a 70% reduced risk of dementia. However, further research is needed, with more comprehensive results expected in 2025.
View original story
Markets
No • 50%
Yes • 50%
Official FDA announcements or press releases
Yes • 50%
No • 50%
Published results in peer-reviewed scientific journals
No • 50%
Yes • 50%
Final study results published by credible scientific journals or announced by the research institutions involved
FDA approved and in market • 25%
Withdrawn by manufacturer • 25%
Rejected by FDA • 25%
Pending approval • 25%
FDA approval status, market reports, and pharmaceutical company announcements
Less than 25% reduction • 25%
70% or more reduction • 25%
50-69% reduction • 25%
25-49% reduction • 25%
Final study results published by credible scientific journals or announced by the research institutions involved
Slightly effective • 25%
Not effective • 25%
Highly effective • 25%
Moderately effective • 25%
Published results in peer-reviewed scientific journals or official announcements from research institutions